Skip to main content
Livermore
Livermore
ZHEN

Payden & Rygel

SEC CIK
0000919219
Latest filing
Jul 31, 2026

LLY holding history

Eli Lilly & Co in every 13F filed by Payden & Rygel, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LLY overviewAll 13F holders of LLYFull Q2 2026 holdings

Shares (Q2 2026)
14,670
Value
$17.6M
% of portfolio
1.4%
Quarters held
22
Since Q1 2021
Holdings of LLY by Payden & Rygel, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,670$17.6M1.4%+5,750+64.5%AddedHolders
Q1 20268,920$8.20M0.6%+5,900+195.4%AddedHolders
Q4 20253,020$3.25M0.2%−100−3.2%ReducedHolders
Q3 20253,120$2.38M0.2%−12,600−80.2%ReducedHolders
Q2 202515,720$12.3M1.0%00.0%UnchangedHolders
Q1 202515,720$13.0M1.1%+6,200+65.1%AddedHolders
Q4 20249,520$7.35M0.6%−3,000−24.0%ReducedHolders
Q3 202412,520$11.1M0.9%−11,700−48.3%ReducedHolders
Q2 202424,220$21.9M1.8%−2,300−8.7%ReducedHolders
Q1 202426,520$20.6M1.4%−3,400−11.4%ReducedHolders
Q4 202329,920$17.4M1.3%00.0%UnchangedHolders
Q3 202329,920$16.1M1.3%−800−2.6%ReducedHolders
Q2 202330,720$14.4M1.0%−74,610−70.8%ReducedHolders
Q1 2023105,330$36.2M2.1%−14,570−12.2%ReducedHolders
Q4 2022119,900$43.9M2.3%−29,200−19.6%ReducedHolders
Q3 2022149,100$48.2M2.8%−3,600−2.4%ReducedHolders
Q2 2022152,700$49.5M3.0%−325−0.2%ReducedHolders
Q1 2022153,025$43.8M2.2%+5,100+3.4%AddedHolders
Q4 2021147,925$40.9M1.9%−1,800−1.2%ReducedHolders
Q3 2021149,725$34.6M1.8%+32,500+27.7%AddedHolders
Q2 2021117,225$26.9M1.3%+107,728+1,134.3%AddedHolders
Q1 20219,497$1.77M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.